120 related articles for article (PubMed ID: 10614360)
1. High-dose therapy for treatment of breast cancer.
Anderson-Reitz L; Mechling BE; Hertz SL
Nurse Pract Forum; 1999 Sep; 10(3):154-8. PubMed ID: 10614360
[TBL] [Abstract][Full Text] [Related]
2. Overview of bone marrow and stem cell transplantation.
Johns A
J Intraven Nurs; 1998; 21(6):356-60. PubMed ID: 10392101
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow and peripheral blood stem cell transplantation for malignancy.
Johnson PW; Simnett SJ; Sweetenham JW; Morgan GJ; Stewart LA
Health Technol Assess; 1998; 2(8):1-187. PubMed ID: 9728295
[No Abstract] [Full Text] [Related]
4. The principles of bone marrow and stem-cell transplantation.
Campbell K
Nurs Times; 1996 Nov 27-Dec 3; 92(48):34-6. PubMed ID: 8974263
[TBL] [Abstract][Full Text] [Related]
5. Home care for stem cell transplantation patients.
MacRae K; Humphreys A; Lind M
Prof Nurse; 1999 Nov; 15(2):87-90. PubMed ID: 10765310
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
Martínez-Climent JA; Comes AM; Vizcarra E; Benet I; Arbona C; Prósper F; Solano C; García Clavel B; Marugán I; Lluch A; García-Conde J
Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.
Schrama JG; Baars JW; Holtkamp MJ; Schornagel JH; Beijnen JH; Rodenhuis S
Bone Marrow Transplant; 2001 Jul; 28(2):173-80. PubMed ID: 11509935
[TBL] [Abstract][Full Text] [Related]
8. Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer.
Rizzo JD; Williams S; Wu JT; Pecora AL; Lazarus HM; Bolwell B; Fields KK; Gale RP; Elfenbein G; Horowitz MM; Antman KH
Bone Marrow Transplant; 2003 Jul; 32(2):151-5. PubMed ID: 12838279
[TBL] [Abstract][Full Text] [Related]
9. Types of bone-marrow and stem-cell transplant.
Campbell K
Nurs Times; 1997 Feb 12-18; 93(7):44-6. PubMed ID: 9095950
[No Abstract] [Full Text] [Related]
10. Patient management strategies and transplantation techniques in european stem cell transplantation centers offering breast cancer patients high-dose chemotherapy with peripheral blood stem cell support: a joint report from the EORTC and EBMT.
Neymark N; Rosti G
Haematologica; 2000 Jul; 85(7):733-44. PubMed ID: 10897126
[TBL] [Abstract][Full Text] [Related]
11. Infectious complications the year after autologous bone marrow transplantation or peripheral stem cell transplantation for treatment of breast cancer.
Barton T; Collis T; Stadtmauer E; Schuster M
Clin Infect Dis; 2001 Feb; 32(3):391-5. PubMed ID: 11170946
[TBL] [Abstract][Full Text] [Related]
12. High-dose therapy in breast cancer: out of favor but not out of promise.
Glück S; Stewart D
Bone Marrow Transplant; 2000 May; 25(10):1017-9. PubMed ID: 10828859
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial.
Yanovich S; Mitsky P; Cornetta K; Maziarz RT; Rosenfeld C; Krause DS; Lotz JP; Bitran JD; Williams S; Preti R; Somlo G; Burtness B; Mills B
Bone Marrow Transplant; 2000 Jun; 25(11):1165-74. PubMed ID: 10849529
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
[TBL] [Abstract][Full Text] [Related]
15. No place for politics.
Fee K
Mod Healthc; 2000 May; 30(21):48, 50. PubMed ID: 11067549
[No Abstract] [Full Text] [Related]
16. A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation.
Pecora AL; Stiff P; LeMaistre CF; Bayer R; Bachier C; Goldberg SL; Parthasarathy M; Jennis AA; Smith AK; Douville J; Chen B; Armstrong RD; Mandalam RK; Preti R
Bone Marrow Transplant; 2001 Aug; 28(3):295-303. PubMed ID: 11535999
[TBL] [Abstract][Full Text] [Related]
17. The sound and the fury: an update on the role of high-dose chemotherapy and autologous stem cell salvage for both metastatic and high-risk breast cancer.
Bar MH
Conn Med; 2000 Jan; 64(1):3-6. PubMed ID: 10697358
[No Abstract] [Full Text] [Related]
18. Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine.
Holmberg LA; Oparin DV; Gooley T; Lilleby K; Bensinger W; Reddish MA; MacLean GD; Longenecker BM; Sandmaier BM
Bone Marrow Transplant; 2000 Jun; 25(12):1233-41. PubMed ID: 10871727
[TBL] [Abstract][Full Text] [Related]
19. [High dosage therapy and autologous peripheral stem cell transplantation in breast carcinoma].
Kier P; Ruckser R; Buxhofer V; Habertheuer KH; Zelenka P; Tatzreiter G; Hübl G; Kittl E; Hauser A; Sebesta C; Hinterberger W
Acta Med Austriaca Suppl; 2000; 52():33-6. PubMed ID: 11261276
[TBL] [Abstract][Full Text] [Related]
20. Treatment options for the patient with breast cancer.
Waltman N
Plast Surg Nurs; 1994; 14(1):15-23. PubMed ID: 7800757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
